Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B

Clinical trial NCT00606099 · WITHDRAWN

Trial details

NCT number: NCT00606099
Sponsor: Novartis
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2007-11-01
Primary completion: 2009-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.